+2,490.2%
NVDL vs BBIO
+656.9%
+1,833.2%
-67.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.2% | -0.1% | -0.1% | -0.2% |
| 7D | -10.3% | -3.2% | -7.1% | -9.9% |
| 30D | -7.1% | -13.6% | +6.5% | -5.1% |
| 3M | +6.6% | +7.2% | -0.7% | +5.0% |
| 6M | +21.1% | +1.5% | +19.6% | +20.4% |
| YTD | +15.2% | -5.3% | +20.5% | +15.2% |
| 1Y | +18.8% | +37.7% | -18.9% | +12.7% |
| 3Y | +649.9% | +153.9% | +496.0% | +553.1% |
| All | +2,490.2% | +656.9% | +1,833.2% | +1,762.5% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling